HR 796
119th Congress
House
Health
Abortion
Consumer affairs
Prescription drugs
Sex and reproductive health
Telephone and wireless communication
Women's health
Second Chance for Moms Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 28, 2025
Referred to the House Committee on Energy and Commerce.
Jan 28, 2025
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Second Chance for Moms Act of 2025
This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
What's happening now
Referred to the House Committee on Energy and Commerce.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). H.R. 796: Second Chance for Moms Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-796/
"H.R. 796: Second Chance for Moms Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-796/.
H.R. 796, 119th Cong. (2026), https://openamerica.io/bill/119-HR-796/.
[H.R. 796: Second Chance for Moms Act](https://openamerica.io/bill/119-HR-796/)